In the current study, we used two colorectal carcinoma cell lines, WiDr and C2BBe1 cells, as well as mesenchymal stem cells (MSCs) to elucidate Nrf2-target protein expression [23, 24]. The gene discussed is NFE2L2; the disease is colorectal carcinoma.